JPH0694518B2 - Method for producing silk fibroin porous body - Google Patents
Method for producing silk fibroin porous bodyInfo
- Publication number
- JPH0694518B2 JPH0694518B2 JP62277957A JP27795787A JPH0694518B2 JP H0694518 B2 JPH0694518 B2 JP H0694518B2 JP 62277957 A JP62277957 A JP 62277957A JP 27795787 A JP27795787 A JP 27795787A JP H0694518 B2 JPH0694518 B2 JP H0694518B2
- Authority
- JP
- Japan
- Prior art keywords
- silk fibroin
- gel
- porous body
- solution
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108010022355 Fibroins Proteins 0.000 title claims description 54
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 27
- 241000255789 Bombyx mori Species 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 239000011148 porous material Substances 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 238000000502 dialysis Methods 0.000 description 14
- 239000006228 supernatant Substances 0.000 description 14
- 239000012528 membrane Substances 0.000 description 12
- 239000001913 cellulose Substances 0.000 description 11
- 229920002678 cellulose Polymers 0.000 description 11
- 239000000523 sample Substances 0.000 description 10
- 238000005119 centrifugation Methods 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 7
- 210000004907 gland Anatomy 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 108010015776 Glucose oxidase Proteins 0.000 description 5
- 238000001879 gelation Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000004366 Glucose oxidase Substances 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000010908 decantation Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229940116332 glucose oxidase Drugs 0.000 description 3
- 235000019420 glucose oxidase Nutrition 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000255794 Bombyx mandarina Species 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000002649 leather substitute Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000012778 molding material Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 229920005606 polypropylene copolymer Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
Landscapes
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Description
【発明の詳細な説明】 〔技術分野〕 本発明は絹フィブロインからなる多孔質体の製造方法に
関するものである。TECHNICAL FIELD The present invention relates to a method for producing a porous body made of silk fibroin.
〔従来技術〕 高分子多孔質体膜はエレクトロニクス工業、食品工業、
化学工業、医薬品工業、医療分野、発酵工業等幅広い産
業分野で使用されている。例えば、酸素固定化用支持体
としてセルロース系多孔質体が使用されるが、この場
合、多孔質体形成用の原液の濃度、凝固浴の組成、温度
の調整等により多孔質体中の孔の形態と大きさとをコン
トロールしなければならず、必ずしも容易な作製法であ
るとはいえない。この他の合成高分子多孔質体の素材と
しては、ポリウレタン、ポリアクリロニトリル、ポリプ
ロピレン、エチレン−ビニルアルコール共重合体などが
あるが、これらのものは種々の孔径を持つ多孔質体の調
製が困難であることから、新しい素材の開発が望まれて
いる。[Prior Art] Polymer porous membranes are used in the electronics industry, food industry,
It is used in a wide range of industrial fields such as the chemical industry, pharmaceutical industry, medical field, and fermentation industry. For example, a cellulosic porous body is used as a support for oxygen immobilization, and in this case, the concentration of the stock solution for forming the porous body, the composition of the coagulation bath, the temperature of the pores in the porous body can be adjusted by adjusting the temperature. The shape and size must be controlled, and it cannot be said that the method is easy. Other materials for the synthetic polymer porous material include polyurethane, polyacrylonitrile, polypropylene, and ethylene-vinyl alcohol copolymer, but these materials are difficult to prepare porous materials having various pore sizes. Therefore, the development of new materials is desired.
特開昭56-166235号公報によれば、生糸を原料として用
い、これを精練してカルシウム塩とエタノールと水から
なる水溶液中に溶解し、得られた溶液を透析処理して絹
フィブロイン水溶液を作り、この水溶液にでんぷん分散
液を加えてゲル化させ、得られたゲル化物を飽和水蒸気
下で加熱してそのゲル化物中に含まれるでんぷんを糊化
した後、この糊化でんぷんをアミラーゼで分解して絹フ
ィブロイン多孔質体を製造する方法が提案されている。According to JP 56-166235 A, raw silk is used as a raw material, which is scoured and dissolved in an aqueous solution of calcium salt, ethanol and water, and the resulting solution is dialyzed to obtain an aqueous silk fibroin solution. After making a starch dispersion into this aqueous solution and gelling it, the gelled product is heated under saturated steam to gelatinize the starch contained in the gelled product, and then the gelatinized starch is decomposed with amylase. Then, a method for producing a silk fibroin porous body has been proposed.
しかし、この方法は、その工程が複雑であり、工業的方
法としては未だ不満足のものである。However, this method has complicated steps and is still unsatisfactory as an industrial method.
本発明は、前記の如き問題を含まない工業的に有利な絹
フィブロイン多孔質体の製造方法を提供することを目的
としている。An object of the present invention is to provide an industrially advantageous method for producing a silk fibroin porous body which does not have the above problems.
本発明によれば、蚕体内から得られた未変性の絹フィブ
ロインの水溶液をpH6以下の条件下に保持して絹フィブ
ロインをゲル化させるか又はその水溶液に絹フィブロイ
ンに対して貧溶媒として作用する水溶性有機溶媒を添加
して絹フィブロインをゲル化させ、得られた含水絹フィ
ブロインゲルを真空条件下で凍結乾燥することを特徴と
する絹フィブロイン多孔質体の製造方法が提供される。According to the present invention, an aqueous solution of unmodified silk fibroin obtained from the silkworm body is allowed to gel under the condition of pH 6 or less to cause silk fibroin to gel, or the aqueous solution acts as a poor solvent for silk fibroin. There is provided a method for producing a porous silk fibroin body, which comprises adding a water-soluble organic solvent to gel silk fibroin, and lyophilizing the resulting hydrous silk fibroin gel under vacuum conditions.
本発明で用いる絹フィブロイン水溶液は、家蚕あるいは
野蚕の体内から得られた未変性の絹フィブロイン溶液を
水に溶解させた希釈水溶液(その絹フィブロイン濃度は
通常10重量%以下である)であり、本発明では、この水
溶液に含まれる絹フィブロインをゲル化させる。絹フィ
ブロインのゲル化は、絹フィブロイン水溶液のpHを6.0
以下、好ましくは2〜4に調整することにより行われ
る。このゲル化処理により、水溶液中に水不溶性の含水
絹フィブロインゲルが沈殿し、この沈殿物を分離回収
し、成形材料として用いて多孔質体を得る。pH調節剤と
しては、酢酸や塩酸等の有機及び無機系の酸水溶液が用
いられる。含水絹フィブロインゲルは、これを真空下で
凍結乾燥することによって、絹フィブロイン多孔質体に
変換される。このようにして得られた多孔質体は、含水
絹フィブロインゲル中に含まれる液体水の蒸発透過によ
り形成される表面に連続する微細孔を内部に有する。The silk fibroin aqueous solution used in the present invention is a diluted aqueous solution obtained by dissolving an undenatured silk fibroin solution obtained from the body of domestic silkworms or wild silkworms in water (the silk fibroin concentration is usually 10% by weight or less). In the invention, the silk fibroin contained in this aqueous solution is gelled. The gelation of silk fibroin is performed by adjusting the pH of the silk fibroin aqueous solution to 6.0.
Hereinafter, it is preferably adjusted to 2 to 4. By this gelation treatment, water-insoluble hydrous silk fibroin gel is precipitated in the aqueous solution, and the precipitate is separated and recovered and used as a molding material to obtain a porous body. As the pH adjuster, organic and inorganic acid aqueous solutions such as acetic acid and hydrochloric acid are used. The hydrated silk fibroin gel is converted into a silk fibroin porous body by freeze-drying it under vacuum. The porous body thus obtained has inside thereof fine pores continuous with the surface formed by evaporation and permeation of liquid water contained in the hydrous silk fibroin gel.
また、絹フィブロインのゲル化は、水溶液のpH調節の
他、水溶液中にアルコールの如きフィブロインに対して
貧溶媒として作用する水溶性有機溶媒を添加することに
よって行うこともできる。In addition, gelation of silk fibroin can be performed by adjusting the pH of the aqueous solution and by adding a water-soluble organic solvent such as alcohol, which acts as a poor solvent for fibroin, to the aqueous solution.
本発明の多孔質体において、その細孔の大きさ(細孔直
径)は、通常0.1〜500μm、好ましくは1〜100μmで
ある。また、多孔質体は、フィルム状や管状の膜体の
他、ブロック状等の任意の形状とすることができる。本
発明では、細孔の大きさは、絹フィブロイン溶液の濃
度、ゲル化のpH条件、ゲル化に用いる貧溶媒の種類及び
濃度、凍結温度等によって調節することができる。In the porous body of the present invention, the size of the pores (pore diameter) is usually 0.1 to 500 μm, preferably 1 to 100 μm. Further, the porous body may have any shape such as a block shape in addition to a film shape or a tubular film body. In the present invention, the size of the pores can be adjusted by the concentration of the silk fibroin solution, the pH condition for gelation, the type and concentration of the poor solvent used for gelation, the freezing temperature, and the like.
本発明においては、このような多孔質体中には、各種酵
素や、医薬品等の薬理活性物質を含有させることができ
る。このような酵素や薬理活性物質を含む多孔質体は、
その製造に際して用いる絹フィブロイン水溶液中に、そ
れら酵素又は薬理活性物質を溶解ないし分散させればよ
い。In the present invention, such a porous body may contain various enzymes and pharmacologically active substances such as pharmaceuticals. Porous materials containing such enzymes and pharmacologically active substances are
These enzymes or pharmacologically active substances may be dissolved or dispersed in the silk fibroin aqueous solution used for the production.
本発明の絹フィブロイン多孔質体は、従来の高分子膜と
同様に種々の分野において利用し得るものであり、例え
ば、血液浄化システム、溶質分離膜、フィルター、細胞
増殖担体、医薬、農薬徐放用担体、酵素固定化支持体、
香料保持体、医療用補てん材、人工皮膚、合成皮革、土
壌改質材等として利用することができる。The silk fibroin porous material of the present invention can be used in various fields like conventional polymer membranes, for example, a blood purification system, a solute separation membrane, a filter, a cell growth carrier, a drug, and a sustained release of agricultural chemicals. Carrier, enzyme-immobilized support,
It can be used as a fragrance holder, a medical prosthesis, an artificial skin, a synthetic leather, a soil modifier, etc.
次に本発明を実施例によりさらに詳細に説明する。 Next, the present invention will be described in more detail with reference to Examples.
実施例1 桑養育の家蚕の熱蚕体内より後部絹糸腺を取り出し、絹
糸腺内の液状絹フィブロインを蒸溜水に分散させて、こ
れを原材料として用いた。送風乾燥により試料濃度を高
めて0.8%の液状絹フィブロインの水溶液を調製した。
この溶液をセルロース製の透析膜装置に入れてpH2.65に
調整した5℃の酢酸水溶液で15時間透析処理すると、セ
ルロース膜透析装置の中にはゲル状態の沈殿部分と上澄
部分との分離が起こった。デカンテーションにより上澄
部分を除去し、ゲル状態の沈殿の沈殿部分をポリエチレ
ンフィルムの上に置いて、−80℃で凍結させた。これを
凍結状態で真空乾燥すると絹フィブロインの多孔質体が
得られた。Example 1 A posterior silk gland was taken out from a heat silkworm body of a mulberry reared domestic silkworm, liquid silk fibroin in the silk gland was dispersed in distilled water, and this was used as a raw material. A 0.8% aqueous solution of liquid silk fibroin was prepared by increasing the sample concentration by blast drying.
This solution was put into a dialysis membrane device made of cellulose and dialyzed with an acetic acid aqueous solution at 5 ° C adjusted to pH 2.65 for 15 hours. In the cellulose dialysis device, the gelled precipitate part and the supernatant part were separated. Happened. The supernatant portion was removed by decantation, and the precipitated portion of the gel-state precipitate was placed on a polyethylene film and frozen at -80 ° C. When this was vacuum dried in a frozen state, a silk fibroin porous material was obtained.
絹多孔膜の試料表面、ならびに断面の走査型電子顕微鏡
写真を観察すると、試料表面は比較的平滑で緻密な構造
となっており、縦断面には約100μmの層状構造が、さ
らに層状構造間には、30〜80μmの直径を有する多孔が
確認された。作製した絹フィブロインの多孔質体を25℃
で12時間蒸留水で浸漬し、含水させ、表面の水滴を軽く
取り除き、水分量を測定したところ、試料の乾燥重量に
対して約8倍の水が含まれていた。Observation of the scanning electron micrograph of the sample surface and cross section of the silk porous film revealed that the sample surface had a relatively smooth and dense structure, with a layered structure of approximately 100 μm in the longitudinal section, and between the layered structures. , The porosity having a diameter of 30 to 80 μm was confirmed. The prepared silk fibroin porous material was placed at 25 ° C.
It was dipped in distilled water for 12 hours to allow it to hydrate, lightly remove the water droplets on the surface, and measure the water content. As a result, about 8 times as much water as the dry weight of the sample was contained.
実施例2 実施例1と同じ0.8%の試料水溶液をセルロース製の透
析膜装置に入れ、これを5℃のpH4.01のフタル酸塩溶液
で15時間透析処理した。得られたゲル状試料と上澄とを
デカンテーションにより分離し、ゲル状試料を−80℃で
凍結させた後、10mmHg以下の減圧下で12時間凍結乾燥さ
せて多孔質体を作製した。実施例1で得られた多孔質体
よりも、表面が固い多孔質体となった。層状構造は若干
崩れたが、3次元的な層状構造が見られる他、多孔質体
の孔径は30μmであった。Example 2 The same 0.8% sample aqueous solution as in Example 1 was placed in a dialysis membrane apparatus made of cellulose, and this was dialyzed with a phthalate solution of pH 4.01 at 5 ° C. for 15 hours. The obtained gel-like sample and the supernatant were separated by decantation, the gel-like sample was frozen at −80 ° C., and then freeze-dried for 12 hours under a reduced pressure of 10 mmHg or less to produce a porous body. The surface of the porous body was harder than that of the porous body obtained in Example 1. Although the layered structure was slightly collapsed, a three-dimensional layered structure was observed and the pore size of the porous body was 30 μm.
比較例1 実施例1、2と同様の手法で、5℃のpH7.76の蒸留水で
15時間透析処理した。この場合にはゲル状試料が得られ
ず、水溶液状態のままであった。この試料を−80℃で凍
結させた後、10-3mmHg以下の減圧下で12時間凍結乾燥さ
せて不織布状の軟らかい多孔質体を作製した。なお、炭
酸ナトリウム水溶液でpHを9.52に調製した溶液で透析処
理した場合にも、ゲル状試料ができず、凍結乾燥の後に
軟らかい多孔質体が得られた。Comparative Example 1 In the same manner as in Examples 1 and 2, distilled water having a pH of 7.76 at 5 ° C was used.
It was dialyzed for 15 hours. In this case, a gel-like sample was not obtained, and it remained in an aqueous solution state. This sample was frozen at −80 ° C. and then freeze-dried for 12 hours under a reduced pressure of 10 −3 mmHg or less to prepare a non-woven fabric-like soft porous body. Even when the solution was adjusted to pH 9.52 with an aqueous sodium carbonate solution, a gel-like sample could not be obtained, and a soft porous body was obtained after freeze-drying.
実施例3 家蚕絹糸腺由来の0.7%絹フィブロイン水溶液のphを調
整することなしに、試料溶液50ml当り2.3mlのメタノー
ルを加えた後、5℃で10時間放置することでゲル状物を
析出させた、デカンテーションにより上澄を除去し、ゲ
ル状物を−30℃で一旦凍結固化させ10-3mmHgの減圧下で
凍結乾燥を行い、多孔質体を得た。得られた多孔質体の
細孔直径はおよそ30〜100μmであった。Example 3 Without adjusting the pH of the 0.7% silk fibroin aqueous solution derived from silkworm silkworm glands, 2.3 ml of methanol was added to 50 ml of the sample solution, and the mixture was left at 5 ° C. for 10 hours to precipitate a gel-like substance. Further, the supernatant was removed by decantation, and the gel-like material was once freeze-solidified at −30 ° C. and freeze-dried under a reduced pressure of 10 −3 mmHg to obtain a porous body. The pore diameter of the obtained porous body was about 30 to 100 μm.
実施例4 0.6%絹フィブロイン水溶液をセルロース製の透析膜装
置に入れ、メタノール2部に水8部を加えた溶液中で5
℃で10時間透析してゲル状物を析出させ、3500rpmの遠
心分離によりゲル状物を上澄から分離した。そのゲル状
物を−45℃で一旦凍結固化させ実施例3と同様に減圧乾
燥することで、2〜10μm直径の多孔質体が得られた。Example 4 A 0.6% aqueous silk fibroin solution was placed in a dialysis membrane apparatus made of cellulose, and the solution was added to a solution obtained by adding 8 parts of water to 2 parts of methanol.
The gel was precipitated by dialysis at 10 ° C for 10 hours, and the gel was separated from the supernatant by centrifugation at 3500 rpm. The gel was freeze-solidified at −45 ° C. and dried under reduced pressure in the same manner as in Example 3 to obtain a porous body having a diameter of 2 to 10 μm.
実施例5 0.6%絹フィブロイン水溶液をセルロース製の透析膜装
置に入れ、メタノール4部に水6部を加えた溶液中で5
℃で10時間透析してゲル状物を析出させ、3500rpmの遠
心分離によりゲル状物を上澄から分離した。−45℃で一
旦凍結固化させた実施例3と同様に減圧乾燥することで
50〜100μm直径の多孔質体が得られた。Example 5 A 0.6% aqueous silk fibroin solution was placed in a dialysis membrane apparatus made of cellulose, and the solution was added to a solution prepared by adding 6 parts of water to 4 parts of methanol.
The gel was precipitated by dialysis at 10 ° C for 10 hours, and the gel was separated from the supernatant by centrifugation at 3500 rpm. By drying under reduced pressure in the same manner as in Example 3 once freeze-solidified at −45 ° C.
A porous body having a diameter of 50 to 100 μm was obtained.
実施例6 0.6%絹フィブロイン水溶液をセルロース製の透析膜装
置に入れ、メタノール6部に水4部を加えた溶液中で5
℃で10時間透析してゲル状物を析出させ、3500rpmの遠
心分離によりゲル状物を上澄から分離した。−45℃で一
旦凍結固化させ実施例3と同様に減圧乾燥することで5
〜30μm直径の多孔質体が得られた。Example 6 A 0.6% aqueous silk fibroin solution was placed in a dialysis membrane apparatus made of cellulose, and the solution was added with 5 parts of a solution prepared by adding 4 parts of water to 6 parts of methanol.
The gel was precipitated by dialysis at 10 ° C for 10 hours, and the gel was separated from the supernatant by centrifugation at 3500 rpm. Once frozen and solidified at −45 ° C. and dried under reduced pressure as in Example 3, 5
A porous body with a diameter of -30 μm was obtained.
実施例7 0.6%絹フィブロイン水溶液をセルロース製の透析膜装
置に入れ、メタノール9部に水1部を加えた溶液中で5
℃で10時間透析してゲル状物を析出させた。遠心分離に
よりゲル状物を上澄から分離することなく、−80℃で一
旦凍結固化させ実施例3と同様に減圧乾燥することで20
〜30μm直径の多孔質体が得られた。Example 7 A 0.6% aqueous silk fibroin solution was placed in a dialysis membrane apparatus made of cellulose, and 5 parts were added in a solution prepared by adding 1 part of water to 9 parts of methanol.
It was dialyzed at 10 ° C. for 10 hours to precipitate a gel. Without separating the gel-like substance from the supernatant by centrifugation, it was freeze-solidified once at −80 ° C. and dried under reduced pressure as in Example 3.
A porous body with a diameter of -30 μm was obtained.
実施例8 0.7%絹フィブロイン水溶液50ccに対して0.5mlの酢酸溶
液を加え、5℃で8時間放置してゲル状物を析出させ、
3500rpmの遠心分離によりゲル状物を上澄から分離し
た。−30℃で一旦凍結固化させ実施例3と同様に減圧乾
燥することで50〜100μm直径の多孔質体が得られた。Example 8 0.5 ml of acetic acid solution was added to 50 cc of 0.7% silk fibroin aqueous solution, and the mixture was allowed to stand at 5 ° C. for 8 hours to precipitate a gel-like substance,
The gel was separated from the supernatant by centrifugation at 3500 rpm. By freeze-solidifying at −30 ° C. and drying under reduced pressure in the same manner as in Example 3, a porous body having a diameter of 50 to 100 μm was obtained.
実施例9 0.6%絹フィブロイン水溶液をセルロース製の透析膜に
入れ、メタノールにより5℃で10時間処理してゲル状物
を析出させた。遠心分離によりゲル状物を上澄から分離
することなく、−45℃で一旦凍結固化させ実施例3と同
様に減圧乾燥することで20〜30μm直径の多孔質体が得
られた。Example 9 A 0.6% aqueous silk fibroin solution was put into a dialysis membrane made of cellulose and treated with methanol at 5 ° C. for 10 hours to precipitate a gel. Without separating the gel from the supernatant by centrifugation, it was freeze-solidified once at -45 ° C and dried under reduced pressure in the same manner as in Example 3 to obtain a porous body having a diameter of 20 to 30 µm.
実施例10 0.6%絹フィブロイン水溶液をセルロース製の透析膜装
置に入れ、メタノール2部に水8部を加えて、5℃で10
時間処理してゲル状物を析出させた。遠心分離によりゲ
ル状物を上澄から分離することなく、−45℃で一旦凍結
固化させ実施例3と同様に減圧乾燥することで30〜60μ
m直径の多孔質体が得られた。Example 10 A 0.6% silk fibroin aqueous solution was placed in a dialysis membrane apparatus made of cellulose, 8 parts of water was added to 2 parts of methanol, and the mixture was added at 10 ° C. at 10 ° C.
It was treated for a time to precipitate a gel. Without separating the gel-like substance from the supernatant by centrifugation, it is freeze-solidified once at -45 ° C. and dried under reduced pressure in the same manner as in Example 3 to obtain 30 to 60 μm.
A porous material having a diameter of m was obtained.
実施例11 吐糸1日前の家蚕の体内より後部絹糸腺を取り出し、水
洗いした後、絹糸腺細胞を除去した液状絹フィブロイン
を蒸留水に分散させ、送風乾燥法により1.5%の絹フィ
ブロイン水溶液を作製した。蒸留水100mlに9.2mgのアセ
チルサルチル酸を、同絹フィブロイン水溶液に溶解さ
せ、セルロース製の透析膜装置に注入し、pH4.0に調整
した酢酸水溶液で12時間透析処理を行った。こうして得
られたゲル状物と上澄液とを温度25℃で3000rpm20分間
遠心分離を行い、沈殿物を温度−80℃で一旦凍結後、10
-3mmHgの減圧下で乾燥を行い、医薬品含有絹蚕白質多孔
質体を得た。36mgの多孔質体を紫外分光光度計用ガラス
製セルに入れ、それに3mlの蒸留水を加えて、多孔質体
から蒸留水中に放出されたアセチルサリチル酸の量を20
6.9nmにおけるUV吸光度の変化として調べ、その結果を
第1表に示す。Example 11 A posterior silk gland was taken out from the body of a silkworm one day before spitting, washed with water, and liquid silk fibroin from which silk gland cells had been removed was dispersed in distilled water to prepare a 1.5% silk fibroin aqueous solution by a blast drying method. . In 100 ml of distilled water, 9.2 mg of acetylsalicylic acid was dissolved in the same silk fibroin aqueous solution, injected into a cellulose dialysis membrane device, and dialyzed with an aqueous acetic acid solution adjusted to pH 4.0 for 12 hours. The gel and the supernatant thus obtained are centrifuged at 3000 rpm for 20 minutes at a temperature of 25 ° C., and the precipitate is once frozen at a temperature of −80 ° C., then 10
The product was dried under reduced pressure of -3 mmHg to obtain a drug-containing silkworm white porous material. 36 mg of the porous body was placed in a glass cell for ultraviolet spectrophotometer, and 3 ml of distilled water was added to it to reduce the amount of acetylsalicylic acid released from the porous body into the distilled water by 20%.
It was examined as a change in UV absorbance at 6.9 nm, and the results are shown in Table 1.
実施例12 家蚕の熟蚕体内より取り出した後部絹糸腺由来の絹フィ
ブロイン水溶液(0.5%)33mlにpH6.86のリン酸塩溶液6
mlを加えた、さらにpH6.86のリン酸塩溶液(6ml)に26.
3mgの酵素グルコースオキシダーゼを溶解し、これを上
記絹フィブロイン水溶液に添加した。25℃で3時間静置
した同絹フィブロイン/グルコースオキシダーゼ混合液
10mlを採取し、これに0.1mlの酢酸を加え、5℃で10時
間静置することでゲル状物の析出を促進させた。3500rp
m、25分間の遠心分離によって上澄を除去し含水状態の
ゲル状物を得た。これを−80℃で一旦凍結させた後、10
-3mmHg以下の減圧下で12時間凍結乾燥することで、グル
コースオキシダーゼを含有する絹フィブロインの多孔質
体を作製した。作製後の多孔質体は−30℃で保存した。 Example 12 Phosphate solution 6 having a pH of 6.86 was added to 33 ml of an aqueous solution of silk fibroin (0.5%) derived from a posterior silk gland taken out from a matured silkworm body of a silkworm.
26 ml to a pH 6.86 phosphate solution (6 ml) with addition of 26 ml.
3 mg of enzyme glucose oxidase was dissolved and added to the above silk fibroin aqueous solution. The same silk fibroin / glucose oxidase mixed solution left standing at 25 ° C for 3 hours
10 ml was collected, 0.1 ml of acetic acid was added thereto, and the mixture was allowed to stand at 5 ° C. for 10 hours to promote precipitation of a gel-like substance. 3500rp
The supernatant was removed by centrifugation at m for 25 minutes to obtain a water-containing gel. After freezing it at -80 ℃,
A silk fibroin porous material containing glucose oxidase was prepared by freeze-drying for 12 hours under a reduced pressure of -3 mmHg or less. The prepared porous body was stored at -30 ° C.
実施例13 実施例12と同様にして調製した絹フィブロイン/グルコ
ースオキシダーゼ混合液をセルロース透析膜装置に入
れ、pH4.01のフタル酸塩溶液を透析液に用い、5℃で10
時間透析処理してゲル状物を析出させた。3500rpm、25
分間の遠心分離により上澄を除去して得たゲル状物を−
80℃で凍結させた後、10-3mmHg以下の減圧下で12時間凍
結乾燥により酵素グルコースオキシダーゼを含有する絹
フィブロイン多孔質体を作製した。Example 13 A silk fibroin / glucose oxidase mixed solution prepared in the same manner as in Example 12 was placed in a cellulose dialysis membrane device, and a phthalate solution having a pH of 4.01 was used as a dialysis solution at 10 ° C at 5 ° C.
It was dialyzed for a period of time to precipitate a gel. 3500 rpm, 25
The gel-like product obtained by removing the supernatant by centrifugation for
After frozen at 80 ° C., a silk fibroin porous material containing the enzyme glucose oxidase was prepared by freeze-drying for 12 hours under reduced pressure of 10 −3 mmHg or less.
実施例14 実施例12あるいは実施例13で得られた酵素含有絹フィブ
ロイン多孔質体を溶存酸素濃度計の電極部に装着し、グ
ルコース濃度の異なるリン酸緩衝液(pH6.4、温度37
℃)にその電極を装入すると、グルコース濃度に対応し
た電流変化、つまり酸素濃度の減少がみられた。実施例
12および13で得られた多孔質体では1×10-6Mから2×1
0-3Mの範囲でグルコース濃度と電流変化量との間に直線
関係が得られた。Example 14 The enzyme-containing silk fibroin porous material obtained in Example 12 or Example 13 was attached to the electrode part of a dissolved oxygen concentration meter, and a phosphate buffer solution having different glucose concentrations (pH 6.4, temperature 37
When the electrode was charged at (° C), a change in current corresponding to glucose concentration, that is, a decrease in oxygen concentration was observed. Example
For porous materials obtained in 12 and 13, 1 × 10 -6 M to 2 × 1
A linear relationship was obtained between glucose concentration and current change in the range of 0 -3 M.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 塚田 ▲ます▼裕 茨城県筑波郡谷田部町大わし1―2 農林 水産省蚕糸試験場内 (56)参考文献 特開 昭56−40156(JP,A) 特開 昭56−166235(JP,A) ─────────────────────────────────────────────────── ─── Continuation of front page (72) Inventor Tsukada ▲ Masuda Yu 1-2 Owashi, Yatabe-cho, Tsukuba-gun, Ibaraki Prefectural Government, Ministry of Agriculture, Forestry and Fisheries, Silkworm Test Station (56) Reference JP-A-56-40156 (JP, A) JP-A-56-166235 (JP, A)
Claims (2)
ンの水溶液をpH6以下の条件下に保持して絹フィブロイ
ンをゲル化させるか又はその水溶液に絹フィブロインに
対して貧溶媒として作用する水溶性有機溶媒を添加して
絹フィブロインをゲル化させ、得られた含水絹フィブロ
インゲルを真空条件下で凍結乾燥することを特徴とする
絹フィブロイン多孔質体の製造方法。1. An aqueous solution of unmodified silk fibroin obtained from a silkworm body is allowed to gel under the condition of pH 6 or less, or the aqueous solution acts as a poor solvent for silk fibroin. A method for producing a porous silk fibroin body, which comprises adding a volatile organic solvent to gel silk fibroin, and freeze-drying the obtained hydrous silk fibroin gel under vacuum conditions.
含有する特許請求の範囲第1項の方法。2. The method according to claim 1, wherein the silk fibroin aqueous solution contains an enzyme or a drug.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62277957A JPH0694518B2 (en) | 1987-11-02 | 1987-11-02 | Method for producing silk fibroin porous body |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62277957A JPH0694518B2 (en) | 1987-11-02 | 1987-11-02 | Method for producing silk fibroin porous body |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01118544A JPH01118544A (en) | 1989-05-11 |
JPH0694518B2 true JPH0694518B2 (en) | 1994-11-24 |
Family
ID=17590630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62277957A Expired - Lifetime JPH0694518B2 (en) | 1987-11-02 | 1987-11-02 | Method for producing silk fibroin porous body |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0694518B2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010116994A1 (en) | 2009-04-06 | 2010-10-14 | 日立化成工業株式会社 | Method for producing porous silk fibroin material |
WO2011126031A1 (en) | 2010-04-06 | 2011-10-13 | 日立化成工業株式会社 | Silk fibroin porous material and method for producing same |
JP2012080915A (en) * | 2010-10-06 | 2012-04-26 | Hitachi Chemical Co Ltd | Wound covering material |
WO2018034111A1 (en) * | 2016-08-19 | 2018-02-22 | 国立研究開発法人理化学研究所 | Composite molding composition including fibroin-like protein, and method for producing composite molding composition |
US11174572B2 (en) | 2015-08-20 | 2021-11-16 | Riken | Composite molding composition including fibroin-like protein, and method for producing composite molding composition |
JP2023127846A (en) * | 2022-03-02 | 2023-09-14 | 国立研究開発法人農業・食品産業技術総合研究機構 | Sericin-containing powder and method for producing sericin-containing powder |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01254621A (en) * | 1988-04-01 | 1989-10-11 | Terumo Corp | Drug carrier, slowly releasing drug and preparation thereof |
JPH02207785A (en) * | 1989-02-08 | 1990-08-17 | Asahi Chem Ind Co Ltd | Porous carrier for cell culture |
US5277811A (en) * | 1992-04-14 | 1994-01-11 | Millipore Corporation | Process for forming porous polymeric product from a nonporous polymeric composition and product |
US5271839A (en) * | 1992-04-14 | 1993-12-21 | Millipore Corporation | Patterned porous polymeric product and process |
JP2526401B2 (en) * | 1993-08-25 | 1996-08-21 | 工業技術院長 | Method for producing environmentally responsive drug controlled release permeable membrane |
JPH11243948A (en) * | 1998-03-02 | 1999-09-14 | Natl Inst Of Sericultural & Entomological Science | Cell culture bed substrate for animal cell propagation and method for preparing the same |
ITVR20010098A1 (en) * | 2001-09-11 | 2003-03-11 | Consorzio Per Gli Studi Uni | PROCEDURE FOR OBTAINING SILK FIBROIN HYDROGELS. |
EP1446169B1 (en) * | 2001-10-25 | 2009-01-14 | University of Connecticut | Fibroin compositions and methods of making the same |
WO2004062697A2 (en) | 2003-01-07 | 2004-07-29 | Tufts University | Silk fibroin materials and use thereof |
EP3231846A1 (en) * | 2003-04-10 | 2017-10-18 | Tufts University | Concentrated aqueous silk fibroin solution and use thereof |
WO2005000483A1 (en) | 2003-06-06 | 2005-01-06 | Tufts University | Method for forming inorganic coatings |
JP4105071B2 (en) * | 2003-10-06 | 2008-06-18 | クラシエホームプロダクツ株式会社 | Gel-like composition and method for producing the same |
JP4056972B2 (en) * | 2003-12-26 | 2008-03-05 | クラシエホームプロダクツ株式会社 | Method for producing gel composition |
CA2608862C (en) * | 2004-06-11 | 2020-05-05 | Trustees Of Tufts College | Silk-based drug delivery system |
US9102916B2 (en) | 2007-02-27 | 2015-08-11 | Trustees Of Tufts College | Tissue-engineered silk organs |
US8187616B2 (en) | 2007-05-29 | 2012-05-29 | Trustees Of Tufts College | Method for silk fibroin gelation using sonication |
CN101970023A (en) | 2008-02-07 | 2011-02-09 | 塔夫茨大学信托人 | 3-dimensional silk hydroxyapatite compositions |
CA2721961A1 (en) | 2008-05-15 | 2009-11-19 | Trustees Of Tufts College | Silk polymer-based adenosine release: therapeutic potential for epilepsy |
US8501172B2 (en) | 2008-09-26 | 2013-08-06 | Trustees Of Tufts College | pH-induced silk gels and uses thereof |
EP2349367A4 (en) | 2008-10-09 | 2013-09-04 | Tufts College | IMPROVED SILK FILMS CONTAINING GLYCEROL |
CA2812635A1 (en) | 2009-07-14 | 2011-01-20 | Trustees Of Tufts College | Electrospun silk material systems for wound healing |
WO2011038401A2 (en) | 2009-09-28 | 2011-03-31 | Trustees Of Tufts College | Drawn silk egel fibers and methods of making same |
IN2012DN02358A (en) | 2009-09-29 | 2015-08-21 | Tufts College | |
WO2011109691A2 (en) | 2010-03-05 | 2011-09-09 | Trustees Of Tufts College | Silk-based ionomeric compositions |
JP6081358B2 (en) | 2010-09-01 | 2017-02-15 | トラスティーズ・オブ・タフツ・カレッジTrustees Of Tufts College | Biomaterials based on silk fibroin and polyethylene glycol |
JP5838026B2 (en) * | 2010-10-06 | 2015-12-24 | 日立化成株式会社 | Surgical hygiene materials |
JP5838025B2 (en) * | 2010-10-06 | 2015-12-24 | 日立化成株式会社 | Anti-adhesive material |
JP5704688B2 (en) * | 2010-10-06 | 2015-04-22 | 日立化成株式会社 | Method for producing silk fibroin porous material |
JP5565629B2 (en) * | 2010-10-06 | 2014-08-06 | 日立化成株式会社 | Method for producing silk fibroin porous material |
AU2011317107B2 (en) | 2010-10-19 | 2016-02-25 | Trustees Of Tufts College | Silk fibroin-based microneedles and methods of making the same |
WO2012145652A1 (en) | 2011-04-20 | 2012-10-26 | Trustees Of Tufts College | Dynamic silk coatings for implantable devices |
EP2811987B1 (en) | 2012-02-06 | 2021-01-20 | Children's Medical Center Corporation | Multi-layer biomaterial for tissue regeneration and wound healing |
WO2013161896A1 (en) * | 2012-04-25 | 2013-10-31 | 日立化成株式会社 | Sustained release carrier for drugs |
JP5978869B2 (en) * | 2012-09-06 | 2016-08-24 | 日立化成株式会社 | Method for producing dried silk fibroin porous material |
JP5823079B2 (en) | 2013-04-25 | 2015-11-25 | Spiber株式会社 | Method for producing polypeptide particles |
WO2014175177A1 (en) | 2013-04-25 | 2014-10-30 | スパイバー株式会社 | Polypeptide hydrogel and method for producing same |
US10065997B2 (en) | 2013-04-25 | 2018-09-04 | Spiber Inc. | Polypeptide porous body and method for producing same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5640156A (en) * | 1979-09-05 | 1981-04-16 | Kanebo Ltd | Porous membrane and its manufacture |
JPS56166235A (en) * | 1980-05-24 | 1981-12-21 | Kanebo Ltd | Hydrophilic porous body and its preparation |
-
1987
- 1987-11-02 JP JP62277957A patent/JPH0694518B2/en not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010116994A1 (en) | 2009-04-06 | 2010-10-14 | 日立化成工業株式会社 | Method for producing porous silk fibroin material |
CN102388094A (en) * | 2009-04-06 | 2012-03-21 | 日立化成工业株式会社 | Method for producing porous silk fibroin material |
WO2011126031A1 (en) | 2010-04-06 | 2011-10-13 | 日立化成工業株式会社 | Silk fibroin porous material and method for producing same |
JP2012080915A (en) * | 2010-10-06 | 2012-04-26 | Hitachi Chemical Co Ltd | Wound covering material |
US11174572B2 (en) | 2015-08-20 | 2021-11-16 | Riken | Composite molding composition including fibroin-like protein, and method for producing composite molding composition |
WO2018034111A1 (en) * | 2016-08-19 | 2018-02-22 | 国立研究開発法人理化学研究所 | Composite molding composition including fibroin-like protein, and method for producing composite molding composition |
JP2023127846A (en) * | 2022-03-02 | 2023-09-14 | 国立研究開発法人農業・食品産業技術総合研究機構 | Sericin-containing powder and method for producing sericin-containing powder |
Also Published As
Publication number | Publication date |
---|---|
JPH01118544A (en) | 1989-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0694518B2 (en) | Method for producing silk fibroin porous body | |
US20040266992A1 (en) | Method for the preparation of silk fibron hydrogels | |
RU2240830C1 (en) | Wound coating and method for its preparing | |
US5089272A (en) | Process for producing capsules having a permeability-controllable membrane | |
EP2424579B1 (en) | Novel collagen materials and methods for obtaining same | |
CH670092A5 (en) | ||
WO2008072379A1 (en) | Method for producing modified biopolymer and method for crosslinking biopolymers | |
CN110540661B (en) | Composite hydrogel of silk fibroin and polyvinyl alcohol, and preparation method and application thereof | |
JPH0611810B2 (en) | Porous chitin molding and method for producing the same | |
Elder et al. | Synthesis and characterization of chitosan scaffolds for cartilage-tissue engineering | |
JP2507885B2 (en) | Silk fibroin hydrogel | |
CN108904874A (en) | With membrane-like medical gel, manufacturing method and its application for promoting the effect of surface of a wound wet union | |
US7763448B2 (en) | Porous body formed of sericin | |
JP2972877B1 (en) | Dope of polymer material, microbeads made of polymer material and method for producing the beads | |
CN105879102B (en) | A kind of feather keratin grafting alginic acid sponge dressing and preparation method thereof | |
JP2729448B2 (en) | Immobilized enzyme membrane | |
CN119075004B (en) | An injectable collagen composite hydrogel and its preparation method and application | |
CN105148323A (en) | Degradable artificial skin scaffold and preparation method thereof | |
RU2824664C1 (en) | Biocompatible matrix based on bacterial cellulose and natural peptides for activating repair processes of damaged tissues | |
JPH02233128A (en) | Oxygen permeable membrane | |
RU2310663C1 (en) | Method for preparing liposome composition with gel synthesized from cysteine and silver nitrate | |
RU2455007C1 (en) | Method for producing gel-forming dextrane phosphates | |
Cherim et al. | Obtaining of collagen biomaterials and their use in the medical field | |
JPH0456593B2 (en) | ||
CN116763977A (en) | Dressing doped with rubidium-containing mesoporous bioactive glass loaded with AIE and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |